LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial
| Autor: | Bergmann, L., Ahrens, M., Albiges, L., Gross Goupil, M., Boleti, E., Gravis, G., Flechon, A., Grimm, M-O.J., Rausch, S., Barthelemy, P., Castellano Gauna, D.E., Mellado Gonzalez, B., Ivanyi, P., Floercken, A., Suarez Rodriguez, C., Maroto Rey, J.P., Gruenwald, V., Burkholder, I., Hartmann, A., Haanen, J.B.A.G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1263-S1263 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|